New hope for advanced cancer: first human trial of ARC101 begins
Disease control
Recruiting now
This early-stage study tests a new drug, ARC101, in about 70 people with advanced solid tumors that have not responded to other treatments. The main goal is to check the drug's safety and how the body processes it. Researchers will also look for signs that the drug shrinks tumors…
Phase: PHASE1 • Sponsor: Third Arc Bio • Aim: Disease control
Last updated May 14, 2026 12:03 UTC